Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Avery Dennison, 3M Settle Patent And Antitrust Litigation - Quick Facts

RELATED NEWS
Trade AVY now with 

Avery Dennison Corp. (AVY: Quote) announced the settlement of its patent and antitrust litigation with 3M company. Avery said the company will continue to sell its OmniCube products worldwide.

The litigation began when 3M alleged that Avery Dennison infringed its patents and sought a preliminary injunction to prevent Avery from selling OmniCube, a Type XI sheeting product used to increase nighttime visibility of road signs and other highway and transportation products. The court denied 3M's request, and after Avery Dennison brought claims of its own for patent infringement and antitrust violations, the companies agreed to dismiss all three pending cases.

Click here to receive FREE breaking news email alerts for Avery Dennison Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After recovering from an initial move to the downside, stocks have shown a lack of direction over the course of the trading day on Tuesday. The choppy trading comes on the heels of the notable pullback seen in the previous session. With lawmakers failing to address corporate tax reform before adjourning for the campaign season, the Treasury Department announced Monday that it is taking targeted action to reduce the tax benefits of corporate tax inversions. Eurozone business activity in September expanded at the slowest pace seen so far this year, adding pressure on the European Central Bank to provide more measures to stimulate the region. The composite output index of the purchasing managers' survey fell to a nine-month low of 52.3 in September from 52.5 in August, preliminary data from Markit Economics showed Tuesday.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.